PharmaLex Group strengthens regulatory expertise in Nordic region

PharmaLex Group, provider of Development Consulting, Regulatory Affairs, Quality Management & Compliance and Pharmacovigilance, Epidemiology and Risk Management worldwide, has enhanced its senior Regulatory Affairs and Development Consulting team with the addition of Dr Cecilia Falkenberg, a leading expert in pre-clinical/clinical research together with global and local regulatory landscapes.

Dr Cecilia Falkenberg joins PharmaLex as Senior Director, Regulatory Affairs and Development Consulting in the Nordics. With her extensive experience, she will lead local and global projects and support clients with Regulatory Affairs and Medical Writing service demands. Falkenberg is responsible for strategically important new projects, communication with regulatory agencies and management of the local PharmaLex team in the Nordic region.

For the past decade, Falkenberg headed the Regulatory Affairs, Pharmacovigilance and Medical Writing Departments at a clinical CRO, where she was maintaining contacts with clients and regulatory agencies and managing the expanding team of clinical professionals.

Her experience includes strategic project planning and governance in national as well as large international projects, implementing various strategies in accordance to the client’s needs and providing specific guidance.

“I have had a great start at PharmaLex and have seen the broad range of services we are able to offer from pre- and post-authorization,” explained Dr Cecilia Falkenberg.

“We have a strong team who are supported by our many affiliates across the globe”, she added. "We are delighted to welcome Cecilia to the team in the Nordics,” said Torben Nørgaard, Managing Director, PharmaLex Nordics.

“Her extensive experience, coupled with our existing expertise is enabling us to provide clients with added value to both local and global projects,” he added.

Falkenberg has a PhD in Medical Biochemistry from Lund University in Sweden and brings along a considerable knowledge from pre-clinical/clinical research together with a firm grasp of the global and local regulatory landscapes.

You may also like